How structured capital differs from traditional VC for pre-IPO companies.

Pre-IPO companies don't always need another priced equity round. Redeemable preference shares, convertible bridges, and structured-yield programs often deliver the same runway without diluting the founders or jamming up the cap table before listing day.

The default move, and where it fails

The default capital move for a growth-stage company in Asia is to raise another priced equity round from venture capital or growth equity. The instrument is familiar, the comparable transactions are easy to point to, and most boards reach for it reflexively.

For a company that is genuinely two-plus years from a listing window, that is often the right call. For a company that is twelve to eighteen months out, it is frequently the wrong one. Three reasons.

One: dilution timing. A priced round at, say, $80M post-money one year before IPO at, say, $200M post-money creates a meaningful new shareholder block at exactly the wrong moment. The pre-IPO investors price the round on private comps; the public market prices the IPO on public comps. The gap between those two valuations is what the founder ends up giving away.

Two: cap-table noise. Each new priced round adds a series of preference shares, liquidation preferences, anti-dilution provisions, and information rights. By the time the IPO bankers arrive to clean the cap table for listing, converting all preferred to common, normalising the share structure, terminating side letters, the legal cost and time consumed is meaningful.

Three: the wrong signal to underwriters. A late priced round done at a steep markup tells public-market underwriters one of two things: either the company has run out of patience, or its private valuation has lost touch with the public comps it will eventually be priced against. Neither is helpful at the IPO marketing stage.

What structured capital actually means

"Structured capital" is a category, not a single instrument. The shared trait is that the capital is shaped to a specific situation rather than fitting the company into a generic vehicle. Three sub-categories matter for pre-IPO companies.

Redeemable Preference Shares (RPS)

RPS sit between debt and equity. The investor receives a defined return, sometimes a coupon, sometimes a structured upside tied to an exit event, and the company commits to redeem the shares at maturity. There is no permanent dilution unless conversion is triggered.

The result, for a pre-IPO company: a 12–24 month runway with no permanent change to the common-share cap table, no priced-round comparable that boxes in the IPO valuation, and a defined economic outcome for the investor that is meaningfully more attractive than a passive bridge note.

This is the structure underlying our own Robinhood Capital Fund: a 12-month MYR 50M programme targeting 15–30% return per annum, with the underlying capital deployed across pre-IPO and listed growth equity, structured lending, and market-making. It is built deliberately to give sophisticated investors institutional-grade access without multi-year private-equity lock-ups, and to give pre-IPO issuers a non-dilutive runway instrument.

Convertible bridges

The convertible note is the simpler cousin of RPS. Capital comes in as debt with a defined coupon, and converts to equity at the IPO at a defined discount or cap. For pre-IPO companies inside the 6–12 month window, convertibles work as a pure bridge: the investor takes the listing risk, the company takes the runway, dilution is deferred until the listing event when public-market pricing is the reference.

Convertibles work best when the listing window is genuinely close and the IPO price discovery is the right moment for dilution to crystallise. They work poorly as a substitute for a priced round when the listing is more than 18 months away. At that distance, the discount/cap mechanics start to misalign with the eventual IPO valuation.

Structured-yield programmes

Structured-yield is a broader category that wraps shorter-duration capital, typically 12 months, around the underlying business. The capital is not priced as equity at all; it is priced as structured debt, sometimes with an equity kicker tied to a defined trigger (typically the IPO).

For listed-issuer treasury or pre-IPO bridge purposes, structured-yield can deliver a meaningfully better return profile to the investor than a fixed deposit, and a meaningfully cheaper cost of capital to the issuer than another priced round, without disturbing the underlying ownership structure.

A worked example

Consider a Southeast Asian growth company with $40M in revenue, targeting a Nasdaq listing in roughly 14 months. Pre-IPO valuation indication is in the $150–180M range. The company needs $8M of working capital to reach the listing milestone.

Option A, priced equity round. Raise $8M at, say, $120M pre-money. New priced shareholder takes 6.25% of the company. At IPO at $180M, the new shareholder's stake is worth $11.25M, a 41% mark-up, which is what most pre-IPO investors are looking for. The founders have surrendered 6.25% permanently.

Option B, RPS / structured. Raise $8M of RPS at, say, 18–22% target return per annum, redeemable at the earlier of IPO or 18 months. Instrument cost to the company over 14 months: approximately $1.9M in defined return. The founders surrender no equity. The investor receives a defined return better than fixed-deposit alternatives, with downside protection through the redemption mechanic.

Both options give the company $8M for 14 months. The difference is who absorbs the long-term value: in Option A, the new shareholder permanently captures the upside between $120M and the eventual public-market valuation; in Option B, the founders retain it.

This is not a universally correct trade. RPS and structured instruments require the investor to underwrite the company's ability to redeem, which means stronger conviction on near-term execution than a passive equity round. The company has to be in good enough shape to take on a defined-return obligation. Where that conviction exists on both sides, the math is meaningfully better than a priced round.

When each instrument is right

A short heuristic we use with founders:

Priced equity round: when the company is genuinely two or more years from a listing window, when meaningful operational work remains and the partner you bring on will be active in that work, when the founders are happy to give away permanent ownership in exchange for that partnership.

RPS / structured: when the company is 12–24 months from a listing window, when the fundamental business is working and the capital need is bridge-shaped (working capital, audit prep, listing costs, marketing), when the founders want to preserve the cap table for the public-market price discovery.

Convertible bridge: when the listing is genuinely 6–12 months out and the only reason for raising is to fund the listing process itself. The IPO becomes the conversion event; dilution is priced at public-market levels rather than late-stage private comps.

Structured-yield: when the company has audited, predictable cash flows and the question is treasury optimisation rather than runway. This is more relevant for listed issuers and post-IPO companies than for pre-IPO situations.

What founders should ask

Three questions move the conversation from "we need to raise" to "we need to raise this specific instrument":

1. What is the listing window I am genuinely targeting? Not the optimistic case. The realistic case where audit is complete, governance is in place, the market is open. Distance to that window dictates instrument.

2. What is the capital actually doing for the next 12 months? Working capital, audit prep, customer acquisition, R&D, headcount? If the answer is "general working capital and IPO costs," structured instruments are usually the better fit.

3. Who do I want around the table at IPO? A priced equity investor will typically be a long-term shareholder; a structured-instrument investor will typically redeem at IPO. There is no right answer, but there is an honest one.

The Robinhood read

We are not philosophically opposed to priced equity rounds. For the right company at the right stage, they remain the cleanest instrument. What we observe is that founders inside the 18-month window default to priced rounds out of habit, when the situation calls for something different.

Robinhood Capital exists, in part, to make structured instruments accessible at the institutional discipline level, without forcing founders into either the dilution penalty of a late priced round or the relationship overhead of a multi-year private-equity partnership. The 12-month RPS structure is one expression of that. Convertibles and structured-yield programmes are others.

If you are 12–18 months from a listing window and your default plan is another priced round, that is the conversation we have most. The math often surprises people.